Cargando…
Collagen fragment biomarkers as serological biomarkers of lean body mass – a biomarker pilot study from the DAHANCA25B cohort and matched controls
BACKGROUND: Loss of muscle mass and function is an important complication to ageing and a range of pathologies, including, but not restricted to, cancer, organ failures, and sepsis. A number of interventions have been proposed ranging from exercise to anabolic pharmacological therapy, with varying s...
Autores principales: | Nedergaard, Anders, Dalgas, Ulrik, Primdahl, Hanne, Johansen, Jørgen, Overgaard, Jens, Overgaard, Kristian, Henriksen, Kim, Karsdal, Morten Asser, Lønbro, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670742/ https://www.ncbi.nlm.nih.gov/pubmed/26673155 http://dx.doi.org/10.1002/jcsm.12027 |
Ejemplares similares
-
Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy -- design of the DAHANCA 31 randomized trial
por: Lonkvist, Camilla K., et al.
Publicado: (2017) -
Serological muscle loss biomarkers: an overview of current concepts and future possibilities
por: Nedergaard, Anders, et al.
Publicado: (2012) -
Type VI collagen turnover-related peptides—novel serological biomarkers of muscle mass and anabolic response to loading in young men
por: Nedergaard, Anders, et al.
Publicado: (2013) -
The Potential of Pathological Protein Fragmentation in Blood-Based Biomarker Development for Dementia – With Emphasis on Alzheimer’s Disease
por: Inekci, Dilek, et al.
Publicado: (2015) -
A caspase-6-cleaved fragment of Glial Fibrillary Acidic Protein as a potential serological biomarker of CNS injury after cardiac arrest
por: Jonesco, Ditte S., et al.
Publicado: (2019)